Gan & Lee Pharmaceuticals. (SHA:603087)
68.15
-0.16 (-0.23%)
Oct 28, 2026, 9:35 AM CST
SHA:603087 Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, SHA:603087 stock has a consensus rating of "Strong Buy" and an average price target of ¥83.50. The average 1-year stock price forecast is 22.52% higher than the current stock price, while the lowest is ¥78.00 (+14.45%) and the highest is ¥89.00 (+30.59%).
Price Target: ¥83.50 (+22.52%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for SHA:603087 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 3 | 3 | 3 | 3 |
Financial Forecast
Revenue This Year
4.98B
from 4.05B
Increased by 23.01%
Revenue Next Year
5.74B
from 4.98B
Increased by 15.19%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is CNY.